Combined use of platelet serotonergic markers and psychopathological scales as diagnostic screening of a psychotic versus a depressive disorder

European Psychiatry

Volumn 18, Issue 7, 2003, Pages 369-371

  Ramirez, Nicolas ^a   Arranz, Belén ^a   Martín, Carmen ^a   San, Luis ^a  

^a HOSPITAL GENERAL DE GRANOLLERS   (Spain)

Author keywords

Depression; Psychopathological scales; Psychosis; Serotonergic function

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; CLOMIPRAMINE; IMIPRAMINE; KETANSERIN; OLANZAPINE; SEROTONIN; SEROTONIN 2A RECEPTOR; TRITIUM;

ADULT; ANHEDONIA; ANOREXIA; ANXIETY; ARTICLE; BINDING SITE; CASE REPORT; COPING BEHAVIOR; DELUSION; DEPRESSION; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DOWN REGULATION; DRUG EFFECT; DYSPHORIA; EATING DISORDER; EMOTION; FEMALE; HELPLESSNESS; HUMAN; INSOMNIA; MAJOR DEPRESSION; MOOD DISORDER; OBSESSION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; PSYCHOSOCIAL WITHDRAWAL; RATING SCALE; SCORING SYSTEM; SCREENING; SEROTONINERGIC SYSTEM; SYMPTOMATOLOGY; THROMBOCYTE; TREATMENT OUTCOME; UPREGULATION; WEIGHT REDUCTION;

EID: 0344876017     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2003.06.005     Document Type: Article

References (5)

1. Arranz B, Rosel P, Sarró S, Ramírez N, Dueñas R, Cano R, et al. Altered platelet serotonin 5-HT2A receptor density and second messenger inositol trisphosphate levels in drug-free schizophrenic patients. Psychiatry Res 2003;118(2):165-74.
2. Copolov D, Crook J. Biological markers and schizophrenia. Aust New Zealand J Psychiatry 2000;34(Suppl): 108-12.
3. Rosel P, Arranz B, San L, Urretavizcaya M, Marcusson J, Navarro MA. 5-HT2A receptors and their second messenger IP3 are only correlated in human brain and not in platelets. Neurosci Res Commun 1999;25(3):129-38.
4. Rosel P, Arranz B, Vallejo J, Alvarez P, Menchon JM, Palencia T, et al. Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patients. J Affect Disord 1999;52: 225-33.
5. Vallejo J, Rosel P, Arranz B, Urretavizcaya M, Menchón JM, Contreras F, et al. Loss of circadian variation of platelet [3H]imipramine binding in delusional compared with non-delusional endogenously depressed patients. J Affect Disord 2002;72(1):95-102.